Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 Stocks That Could Be the Next Biotech Buyouts


Biotech investors are on the edge of their seats this holiday season thanks to a recent string of juicy buyout offers. Despite a busy year for acquisitions, big pharmaceutical companies with pipelines to fill and money to spend have been jumping over each other to acquire smaller biotechs at steep premiums.

Which of today's smaller biotechs will be the next one that inspires pharmaceutical giants to open their checkbooks wide? Arrowhead Pharmaceuticals (NASDAQ: ARWR), Blueprint Medicines (NASDAQ: BPMC), and Deciphera Pharmaceuticals (NASDAQ: DCPH) are on big pharma's Christmas list. Here's why.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments